Filtered By:
Cancer: Ovarian Cancer
This page shows you your search results in order of date. This is page number 19.
Order by Relevance | Date
Total 484 results found since Jan 2013.
Stanford Researchers Create “ Evolved ” Protein That May Stop Breast & Ovarian Cancers From Spreading
Early but promising tests in lab mice suggest that a bioengineered protein therapy, administered intravenously, may halt the spread of breast and ovarian cancers from their original tumor sites. Mice with ovarian cancer had a 90 percent reduction in metastatic nodules when treated with the engineered decoy protein. This approach might one day provide an […]
Source: Libby's H*O*P*E* - September 24, 2014 Category: Cancer & Oncology Authors: Paul Cacciatore Tags: Medical Study Results Novel Therapies Preclinical Testing Amato Giaccia Ph.D. Axl protein bioengineering cancer metastases Dana-Farber Cancer Institute decoy protein directed evolution Gas6 protein Glenn Dranoff M.D. Greg Lemke I Source Type: blogs
Stanford Researchers Create “Evolved” Protein That May Stop Breast & Ovarian Cancers From Spreading
Early but promising tests in lab mice suggest that a bioengineered protein therapy, administered intravenously, may halt the spread of breast and ovarian cancers from their original tumor sites. Mice with ovarian cancer had a 90 percent reduction in metastatic nodules when treated with the engineered decoy protein. This approach might one day provide an […]
Source: Libby's H*O*P*E* - September 24, 2014 Category: Cancer & Oncology Authors: Paul Cacciatore Tags: Medical Study Results Novel Therapies Preclinical Testing Amato Giaccia Ph.D. Axl protein bioengineering cancer metastases Dana-Farber Cancer Institute decoy protein directed evolution Gas6 protein Glenn Dranoff M.D. Greg Lemke I Source Type: blogs
Wit, conflict of interest, and John Donne
Last weekend the Taylor University theater department performed Wit, a Pulitzer Prize winning play written by Margaret Edson in 1993. I had the interesting experience of being the medical consultant for the play. The main character Vivian is a professor of English literature who specializes in the Holy Sonnets of John Donne and is dying of metastatic ovarian cancer. The entire play takes place in... // Read More »
Source: blog.bioethics.net - September 24, 2014 Category: Medical Ethics Authors: Steve Phillips Tags: Health Care bioethics Consent / Research syndicated Source Type: blogs
A New Approach to Targeting Metastasis in Cancer
Most cancers kill through metastasis, the spread of cancerous cells throughout the body to seed numerous secondary tumors. Without this process cancer would be much less threatening and more amenable to treatment. Thus numerous research groups are investigating ways to shut down or otherwise interfere with metastasis, and here is a recent example:
[Researchers have] developed a protein therapy that disrupts the process that causes cancer cells to break away from original tumor sites, travel through the blood stream and start aggressive new growths elsewhere in the body. Today doctors try to slow or stop metastasis with ch...
Source: Fight Aging! - September 23, 2014 Category: Research Authors: Reason Tags: Daily News Source Type: blogs
Role For Gemcitabine As Second-line Chemotherapy in Recurrent Clear Cell Ovarian Cancer
In a recent 2014 retrospective analysis involving 72 recurrent ovarian clear cell patients who underwent second-line therapy at one of 20 Italian centers over a 16-year period, the researchers noted that a small subgroup of patients who received the drug gemcitabine (Gemzar®) appeared to have a higher rate of tumor response, as compared to women […]
Source: Libby's H*O*P*E* - September 21, 2014 Category: Cancer & Oncology Authors: Paul Cacciatore Tags: Chemotherapy Medical Study Results Molecular Diagnostics Cancer Treatment Centers of America chemosensitivity and resistance assay dasatinib (Sprycel) ENMD-2076 genomic tumor profiling Maurie Markman M.D. MITO-9 ovarian cancer ovaria Source Type: blogs
Dana Farber Webchat: The Latest in Ovarian Cancer Treatment & Research
The latest in ovarian cancer treatment and research is addressed via a Dana-Farber Cancer Institute webchat that was conducted live on September 16, 2014.
Source: Libby's H*O*P*E* - September 20, 2014 Category: Cancer & Oncology Authors: Paul Cacciatore Tags: Anti-Vascular Drugs Biological Therapies Chemotherapy Clinical Trials Diagnosis & Treatment Diet & Nutrition Genetics Genomic Tumor Profiling Immunotherapy Novel Therapies Pipeline Drugs Prevention Prognosis Targeted Therapies Source Type: blogs
Dana Farber Webchat: The Latest in Ovarian Cancer Treatment & Research
The latest in ovarian cancer treatment and research is addressed via a Dana-Farber Cancer Institute webchat that was conducted live on September 16, 2014.
Source: Libby's H*O*P*E* - September 20, 2014 Category: Cancer & Oncology Authors: Paul Cacciatore Tags: Anti-Vascular Drugs Biological Therapies Chemotherapy Clinical Trials Diagnosis & Treatment Diet & Nutrition Genetics Genomic Tumor Profiling Immunotherapy Novel Therapies Pipeline Drugs Prevention Prognosis Targeted Therapies Source Type: blogs
Improved Survival of Ovarian Cancer Patients Receiving Treatment Guided by Comprehensive Tumor Profiling
Data from an ovarian cancer registry presented at the 2014 European Society for Gynaecological Oncology (ESGO) annual meeting reinforce comprehensive tumor profiling as a “game changer” for oncologists.
Source: Libby's H*O*P*E* - September 19, 2014 Category: Cancer & Oncology Authors: Paul Cacciatore Tags: Biomarker Genomic Tumor Profiling Molecular Diagnostics Targeted Therapies Andreas Voss Caris Life Sciences Caris Molecular Intelligence European Society for Gynaecological Oncology Gilda Witte CEO Ovarian Cancer Action Prof. Hani Gabra Source Type: blogs
